I don't think this is safe to assume at all. They didn't wake up the other day and realise anything - they have had a hand in steering the company as directors for a long time.
You don't think the change at the top of Canopy might of had something to do with it? Coincidence that they lob the head of the founder of Canopy (who was also a director of Auscann) and then soon after cut the ties and direction that he had, that they don't agree with? Some coincendence?
Lobbing the head of the founder would of been determined to be short term pain for long term gain. They would of thought the same with the Auscann shares sale.
What happens next is the telling part. They have cash and maybe Canopy wanted Auscann to focus on parts of the market that Canopy wasn't intending to be strong in - that would explain the situation so far (with the shelving of established licences etc.). Maybe acquisitions are now on the agenda for Auscann?
I prefer they still have lots of cash and no Canopy then Canopy and no cash.
It's a speccy! If you thought the share price wasn't going to bounce around when you bought, you were wrong.
- Forums
- ASX - By Stock
- News: AC8 Auscann Group Says Canopy Growth Sold Its 13.2% Interest In Co
I don't think this is safe to assume at all. They didn't wake up...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online